Enadenotucirev is an investigational oncolytic virus that is in clinical trials for various cancers. Enadenotucirev is an investigational oncolytic virus that is in clinical trials for various cancers. It is an oncolytic A11/Ad3 Chimeric Group B Adenovirus, previously described as ColoAd1.